Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes

R. J. Caselli, A. C. Dueck, D. E.C. Locke, M. N. Sabbagh, G. L. Ahern, S. Z. Rapcsak, L. C. Baxter, R. Yaari, B. K. Woodruff, C. Hoffman-Snyder, R. Rademakers, S. Findley, E. M. Reiman

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

Objective: To characterize the effects of cerebrovascular (CV) risk factors on preclinical memory decline in cognitively normal individuals at 3 levels of genetic risk for Alzheimer disease (AD) based on APOE genotype. Methods: We performed longitudinal neuropsychological testing on an APOE ε4 enriched cohort, ages 21-97. The long-term memory (LTM) score of the Auditory Verbal Learning Test (AVLT) was the primary outcome measure. Any of 4 CV risk factors (CVany), including hypercholesterolemia (CHOL), prior cigarette use (CIG), diabetes mellitus (DM), and hypertension (HTN), was treated as a dichotomized variable. We estimated the longitudinal effect of age using statistical models that simultaneously modeled the cross-sectional and longitudinal effects of age on AVLT LTM by APOE genotype, CVany, and the interaction between the two. Results: A total of 74 APOE ε4 homozygotes (HMZ), 239 ε4 heterozygotes (HTZ), and 494 ε4 noncarriers were included. APOE ε4 carrier status showed a significant quadratic effect with age-related LTM decline in all models as previously reported. CVany was associated with further longitudinal AVLT LTM decline in APOE ε4 carriers (p = 0.02), but had no effect in noncarriers. When ε4 HTZ and HMZ were considered separately, there was a striking effect in HMZ (p < 0.001) but not in HTZ. In exploratory analyses, significant deleterious effects were found for CIG (p = 0.001), DM (p = 0.03), and HTN (p = 0.05) in APOE ε4 carriers only that remained significant only for CIG after correction for multiple comparisons. Conclusion: CV risk factors influence age-related memory decline in APOE ε4 HMZ.

Original languageEnglish (US)
Pages (from-to)1078-1084
Number of pages7
JournalNeurology
Volume76
Issue number12
DOIs
StatePublished - Mar 22 2011

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes'. Together they form a unique fingerprint.

  • Cite this

    Caselli, R. J., Dueck, A. C., Locke, D. E. C., Sabbagh, M. N., Ahern, G. L., Rapcsak, S. Z., Baxter, L. C., Yaari, R., Woodruff, B. K., Hoffman-Snyder, C., Rademakers, R., Findley, S., & Reiman, E. M. (2011). Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes. Neurology, 76(12), 1078-1084. https://doi.org/10.1212/WNL.0b013e318211c3ae